Dynavax Technologies
DVAX
#5491
Rank
A$1.93 B
Marketcap
A$16.51
Share price
0.00%
Change (1 day)
-17.59%
Change (1 year)

Dynavax Technologies (DVAX) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.80 Billion

According to Dynavax Technologies 's latest financial reports the company has A$0.80 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Dynavax Technologies - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.95 B5.08%
2023-12-31$A$0.91 B6.94%
2022-12-31$A$0.85 B178.35%
2021-12-31$A$0.30 B301.84%
2020-12-31$A$76.33 M544.66%
2019-12-31$A$11.84 M-86.77%
2018-12-31$A$89.52 M-64.98%
2017-12-31$A$0.25 B106.55%
2016-12-31$A$0.12 B-51.81%
2015-12-31$A$0.25 B109.16%
2014-12-31$A$0.12 B-41.21%
2013-12-31$A$0.20 B89.02%
2012-12-31$A$0.11 B13.43%
2011-12-31$A$97.41 M89.88%
2010-12-31$A$51.3 M622.79%
2009-12-31$A$7.09 M-69%
2008-12-31$A$22.89 M-48.84%
2007-12-31$A$44.75 M-55.38%
2006-12-31$A$0.10 B-1.3%
2005-12-31$A$0.10 B31.35%
2004-12-31$A$77.37 M-200.55%
2003-12-31$-A$76.96 Million-23.09%
2002-12-31$-A$0.11 Billion48.37%
2001-12-31$-A$67.44 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-A$0.43 Billion-152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$27.43 B 3,308.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$78.20 B 9,617.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$32.32 B 3,916.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$69.25 B 8,506.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
A$31.90 B 3,864.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$140.25 B 17,329.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$10.92 B 1,258.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
A$14.49 B 1,700.85%๐Ÿ‡บ๐Ÿ‡ธ USA